Complex, High-Risk and Indicated Percutaneous Coronary Interventions and Advanced Hemodynamic Care (CHIP) Fellowship
Program Director and Director of Catheterization Laboratory: Khaldoon Alaswad, M.D.
For application information and questions please contact: Theresa Gary, phone:
- Duration of training: 1 year
- Number of positions: 1
- Prerequisite training: 3 year general cardiology fellowship and 1 year interventional cardiology fellowship
Improvements in percutaneous coronary artery technologies and trends in the treatment of coronary artery disease have led to the growth in referrals for percutaneous coronary intervention (PCI) in hemodynamically unstable and/or anatomically complex patients. Such patients represent a challenging but rewarding field governed by robust data.
Aligned with our commitment to medical education and cutting-edge innovation, the Henry Ford Division of Cardiology fully supports a non-ACGME accredited Complex, High-Risk and Indicated Percutaneous Coronary Interventions and Advanced Hemodynamic Care Fellowship (CHIP) program to meet this expanding need. As one of the few centers in the nation with the procedural volumes, clinical research trials, expert faculty, and program infrastructure to provide this training, Henry Ford is uniquely positioned to fulfill the educational need.
The selected trainee will engage in a combination of clinical work and research, with direct mentoring provided by the Program Director and Faculty. Upon completion of this fellowship, physicians will have learned to competently evaluate and treat complex coronary disease and provide advanced hemodynamic management and therapies. This program aims to provide the foundation for a fellowship trainee to embark on a successful career in Interventional Cardiology with a specific career-directed focus upon:
- Operator excellence in performing PCI in patients with chronic total occlusions (CTOs) and other high-risk criteria, including those needing hemodynamic support both during and after PCI
- The knowledge and principles of advanced non-invasive and invasive hemodynamic assessments
- Coordinating the successful care of patients with advanced cardiac dysfunction and/or a heart failure (HF), focusing specifically on those requiring mechanical cardiac support
- The optimal timing and role for coronary revascularization in patients with ventricular dysfunction including risk assessment prior to and during coronary revascularization via percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG)
- Clinical and/or translational research in any and all of the above arenas